Diabetes Master Clinician Series

Seems ever daunting to keep up with all the changes of type 2 diabetes management? Join us to review the most up-to-date ADA’s standards of care. Topics will include the pharmacotherapy and clinical use of continuous glucose monitoring. Come and take away practical key updates in diabetes in just 30 minutes!

“Don’t eat anything white” is not enough. As the provider and clinician, you have to say something more, especially if you have just given your patient their diagnosis of pre-diabetes or maybe type 2 diabetes. Understanding your limited visit time with patients, you have to be concise and help people move to action without feeling like they can’t ever eat a potato or piece of bread again. Join us for tips for a quick assessment, helping patients identify their own strategies for change, finding resources and agreeing to go to that important appointment for Medical Nutrition Counseling (MNT) and/or comprehensive education. You don’t have to be the expert, but you have to help people get started. You Can Do This!

Diabetes drugs are taking Hollywood by storm.  This includes novel agents like the GLP-1 receptor agonists dulaglutide (Trulicity), semaglutide (Ozempic), and others. There is also the new dual GLP-1/GIP agonist tirzepatide (Mounjaro).  But are these drugs safe?  Are there risks to using in people without diabetes? And is this contributing to shortages for people with diabetes?  This is a “can’t miss” MCS as we learn answers to these questions and all of the practical pearls about these drugs including their safety, dosing, and expected weight loss.